Mononuclear phagocytes in head and neck squamous cell carcinoma.
about
Immune suppression in head and neck cancers: a reviewIn Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.Immune alterations and immunotherapy prospects in head and neck cancer.In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients.Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
P2860
Mononuclear phagocytes in head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@en
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@nl
type
label
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@en
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@nl
prefLabel
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@en
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@nl
P2093
P2860
P921
P1476
Mononuclear phagocytes in head and neck squamous cell carcinoma.
@en
P2093
Hans Jørgen Aarstad
John-Helge Heimdal
Kenneth Wilfried Kross
P2860
P2888
P304
P356
10.1007/S00405-009-1153-Y
P577
2009-12-05T00:00:00Z
2010-03-01T00:00:00Z